Assessment of Hemoglobin A1c Management and Prescription Cost Due to Polypharmacy Among Patients With Diabetes in Iran Based on the STEPS Iran 2016 Survey and a Prescription Database: A Multi-level, Cross-sectional National Study

CONCLUSION: Our results demonstrated that diabetics with polypharmacy paid significantly more for their prescriptions without experiencing a positive effect on the control of HbA1c levels.PMID:38431954 | PMC:PMC10915928 | DOI:10.34172/aim.2024.01

Source: Archives of Iranian Medicine - March 3, 2024 Category: Middle East Health Authors: Mojdeh Daneshmand Hamidreza Jamshidi Mohammad Hadi Farjoo Mohammad Reza Malekpour Erfan Ghasemi Seyede Salehe Mortazavi Mohsen Shati Farshad Farzadfar Source Type: research